Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

LIXT Stock Annual Income Statement. Download in Excel

Lixte Biotechnology Holdings Inc. logo

Lixte Biotechnology Holdings Inc.

Sector: Healthcare   

Industry: Biotechnology

1.98
 
USD
  
0.07
  
(3.66%)
Previous close: 1.91  Open: 1.95  Bid: 1.85  Ask: 2.15
52 week range    
1.31   
   4.40
Mkt Cap: 5 M  Avg Vol (90 Days): 617,754
Peers   
UTHR / 
HBSI / 
Last updated: Monday 23rd December 2024

Stock Rankings

40
Value
23
Quality
How are these ranks calculated?
Search for a stock

Financials

LIXT Income Statement

Annual
Invalid dateDec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-4.0-2.66
Basic EPS total-4.0-2.66
Basic weighted shares outstanding5 M6 M6 M1 M1 M1 M2 M2 M
Cost of sales-25000.0765085.03 M3 M
Diluted EPS total-0.4-0.3-0.4-2.4-2.9-5.0-4.0-2.66
Diluted normalized net income/share-0.4-0.3-0.4-2.4-2.9-5.0-2.66
Diluted weighted shares outstanding5 M6 M6 M1 M1 M1 M2 M2 M
GainOnSaleOfSecurity183.01375.04923.049723.04342.0626.011195.017486.0
GeneralAndAdministrativeExpense1 M1 M2 M2 M765085.03 M3 M2 M
Gross operating profit25000.0-765085.0-3 M-3 M
Income before tax-2 M-2 M-2 M-2 M-3 M-7 M-6 M-5 M
Income restructuring and M&A-25000.0
InterestExpenseNonOperating3674.07414.08875.016233.0
MiscOtherSpecialCharges34016.0
Net income from total operations-2 M-2 M-2 M-2 M-3 M-7 M-6 M-5 M
NetIncomeCommonStockholders-2 M-2 M-2 M-2 M-3 M-7 M-6 M-5 M
NetIncomeContinuousOperations-2 M-2 M-2 M-2 M-3 M-7 M-6 M-5 M
NetNonOperatingInterestIncomeExpense-3674.0-7414.0-2320.0-1253.0
NonRecurringOperationExpense553173.0729171.01 M978244.0
Normalized income-3 M
Operating income-2 M-2 M-2 M-2 M-3 M-7 M-6 M-5 M
Operating income before depreciation (EBITDA)-2 M-2 M-2 M-2 M-3 M-7 M-6 M-5 M
OperatingExpense2 M2 M2 M2 M3 M7 M6 M5 M
Other income net-183.0-1375.0-4923.0-49723.0-4342.0-626.0-3374.01954.0
OtherGandA1 M1 M2 M2 M765085.03 M3 M2 M
OtherOperatingExpenses724506.01 M1 M1 M
Research & development expense870006.0467258.040703.0820906.01 M2 M1 M898100.0
ResearchExpense870006.0467258.040703.0820906.01 M2 M1 M898100.0
RestructringAndMnAIncome-25000.0
SalariesAndWages-287159.0-70695.0-833612.0-748655.01 M3 M2 M670000.0
Selling Gen & administrative expense1 M1 M2 M2 M765085.03 M3 M2 M
SellingAndMarketingExpense-422631.0-765085.0
Special income/charges25000.0-553173.0-729171.0-1 M-978244.0
Total Income available for interest expense (EBIT)-2 M-2 M-2 M-2 M-3 M-7 M-6 M-5 M
Total common shares outstanding1 M1 M1 M2 M2 M
Total net income-2 M-2 M-2 M-2 M-3 M-7 M-6 M-5 M
Total ordinary shares2 M2 M2 M2 M2 M2 M2 M2 M
TotalExpenses2 M2 M2 M2 M4 M10 M6 M5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University